-
Touchlight and LenioBio Collaborate to Accelerate Development of Protein Therapeutics for Pandemic Response
Biotech Newswire
July 03, 2024
Touchlight and LenioBio collaborate deeply to further demonstrate the breadth of dbDNA applications.
-
Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification
PharmaSources
May 14, 2024
The life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing.
-
Boost for CGT market as AztraZeneca collaborates with Cellectics
Shem Oirere
November 16, 2023
UK-based Anglo-Swedish multinational pharmaceutical and biotechnology company, AztraZeneca Plc, announced on November 1, a deal with another company in the fast-growing CGT market.
-
SeraNovo and AstraZeneca to Collaborate on Research Projects
PharmaSources
May 16, 2023
SeraNovo is pleased to announce the closing of a multi-compound deal with AstraZeneca.SeraNovo (Leiden, The Netherlands) is pleased to announce the closing of a multi-compound deal with AstraZeneca.
-
ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
PharmaSources.com
January 10, 2023
ProBioGen announced today a new non-exclusive collaboration with Boehringer Ingelheim on ProBioGen's DirectedLuck® transposase technology.
-
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle-Income Countries
PharmaSources.com
April 12, 2022
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
-
BioGenes and Alphalyse Collaborate to Optimize ELISA Reagent Characterization for Biomanufacturing
b3cnewswire
February 10, 2022
2D gel analytics and LC-MS are the most common methods for HCP reagent characterization, and should ideally both be used to maximize...
-
Humanigen and Cenexi Collaborate to Manufacture Lenzilumab in France
contractpharma
February 09, 2022
CDMO Cenexi to become preferred drug product supplier for France and the EU.
-
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate
prnasia
January 29, 2022
HaemaLogiX Ltd (HaemaLogiX), the clinical-stage biotechnology company developing novel monoclonal antibody therapies for multiple myeloma, and Lonza, a global development and manufacturing partner to the pharma...
-
West, Corning Collaborate to Enable Advanced Pharmaceutical Injectable Drug Delivery
contractpharma
January 25, 2022
Aim to advance patient safety and expand access to life-saving treatments.